Physician profile
Griselda E Tiu
NPI 1619088440
$1,148.60
in general payments reported to CMS, 2019-2025
9 companies · $526 in 2025
The $526 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $82.21 · 2023: $505 · 2024: $35.29 · 2025: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $916 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $916.39 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $174.83 | 2025 | |
| Novo Nordisk INC | $174.79 | 2023-2025 | Wegovy |
| Dexcom, INC. | $151.05 | 2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor |
| Sanofi-Aventis U.S. LLC | $150.00 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $134.47 | 2023 | |
| Boston Scientific Corporation | $125.00 | 2023 | Watchman Access System |
| Gilead Sciences, INC. | $120.96 | 2023 | Vemlidy |
| Medtronic Vascular, INC. | $82.21 | 2020 | |
| Medtronic, INC. | $35.29 | 2024 | Intellis Adaptivestim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Griselda Tiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.